Sunday, November 1, 2026

Ultra-Wealthy Americans Relocate to Zero-Tax States, Save Millions Annually

Billionaires are moving from high-tax U.S. states like Hawaii to zero-tax jurisdictions like Florida, saving up to $11 million annually on $100 million in capital gains. The pattern mirrors global tax migration trends as wealthy individuals seek jurisdictions with favorable tax treatment, similar to movements within the EU and from high-tax nations to Switzerland and Monaco.

LM Salvado
LM Salvado

March 17, 2026

Ultra-Wealthy Americans Relocate to Zero-Tax States, Save Millions Annually
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Ultra-high-net-worth Americans are relocating from Hawaii to Florida to eliminate state income tax, saving up to $11 million yearly on $100 million in realized capital gains, according to substrate.com analysis. The migration mirrors global tax optimization patterns seen in Europe, where wealthy individuals move to Switzerland, Monaco, or Dubai to reduce tax burdens.

Nine U.S. states levy no income tax—Alaska, Florida, Nevada, New Hampshire, South Dakota, Tennessee, Texas, Washington, and Wyoming—creating internal tax havens within a single nation. Hawaii's top rate of 11% matches or exceeds rates in several European countries, while Florida's zero percent resembles Gulf states like the UAE. A billionaire shifting from California faces combined federal-state rates exceeding 50% on short-term gains, comparable to top rates in France or Denmark.

Legal domicile requires more than property ownership. Wealthy migrants must spend 183+ days annually in their new state, register vehicles, and obtain local driver's licenses. California and New York audit former residents using credit card data and phone location tracking, enforcement tactics similar to those deployed by HMRC in the UK or tax authorities in Germany against emigrating citizens.

The concentration of ultra-wealthy buyers in Florida's Palm Beach and Miami Beach could accelerate price appreciation for properties above $20 million, while Hawaii faces tax base erosion and potential revenue shifts to middle-income residents. This dynamic parallels London's property market, where international wealth concentration has priced out domestic buyers in prime areas.

Wealth managers report 18-24 month planning horizons for clients establishing defensible domicile before major liquidity events. If federal capital gains rates rise by 5 percentage points, state tax elimination becomes proportionally more valuable, potentially accelerating migration. Some destination states may eventually implement wealth or luxury property transfer taxes, though Republican-controlled legislatures currently resist such measures—a contrast to wealth tax proposals advancing in Spain, Norway, and other European nations.

About this analysis

This is a Via News analysis. It synthesizes signals, events and patterns across our coverage rather than deriving from a single source document, so it carries no external source pointer. Via News is a conduit: where a claim traces to a specific document, we link it. How we source

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com